Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS -Mutant Cancers
2012
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer
2006
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
2008 Standout
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
2004 Standout
Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial
2016 Standout
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
2017
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
2009 Standout
Thioredoxin, a mediator of growth inhibition, maps to 9q31
1995
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
2002
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
2009 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
1998
Late Adrenal Metastasis in Operable Non–Small-Cell Lung Carcinoma
2002
Mediastinal Lymph Node Dissection versus Mediastinal Lymph Node Sampling for Early Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
2014
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
2007
Surgery for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review of the Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Approaches to Lobectomy
2008
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules
2013 Standout
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Autophagy as a cell death and tumor suppressor mechanism
2004 Standout
Lung Cancer
2008 Standout
Resistance mechanisms to cancer chemotherapy
2008
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Complete resection in lung cancer surgery: proposed definition
2005
Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas
2005
The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers
1996 Standout
Molecular pathogenesis of lung cancer
1999
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2004
Hypermethylation of the Death-Associated Protein (DAP) Kinase Promoter and Aggressiveness in Stage I Non-Small-Cell Lung Cancer
2000
von Hippel-Lindau Disease
1997 StandoutNobel
Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma
2005
RAS Is Regulated by the let-7 MicroRNA Family
2005 Standout
Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Lymph Node Dissection in Clinical Stage I Lung Cancer: A Meta-Analysis and System Review
2016
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer
2007 Standout
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
2006 Standout
Limited Resection for the Treatment of Patients With Stage IA Lung Cancer
2010
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer
2002
Lung Cancer Staging: A Case for a New T Definition
2006
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
TP53 mutation, allelism and survival in non-small cell lung cancer
2005
Preferential DNA Damage and Poor Repair Determine ras Gene Mutational Hotspot in Human Cancer
2002
Cytogenetic and molecular aspects of lung cancer
2005
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Blocking Oncogenic Ras Signaling for Cancer Therapy
2001
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Characterization and chromosomal assignment of yeast artificial chromosomes containing human 3p13-p21-specific sequence tagged sites
1995
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
2005 Standout
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Physiological functions of thioredoxin and thioredoxin reductase
2000 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
MicroRNA signatures in human cancers
2006 Standout
Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung
2001
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
2005 StandoutNature
Neutrophils in cancer: neutral no more
2016 Standout
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Lung Cancer in Women
2005
Survival Following Lobectomy and Limited Resection for the Treatment of Stage I Non-small Cell Lung Cancer ≤ 1 cm in Size
2010
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Progress in understanding the molecular pathogenesis of human lung cancer
1998
How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations
2006
Molecular genetic analysis of the von Hippel-Lindau disease (VHl) tumour suppressor gene in gonadal tumours
1995
The VHL tumour-suppressor gene paradigm
1998 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma
1996
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
2001
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial
2011
Integration of Platinum Nanoparticles with a Volumetric Bar‐Chart Chip for Biomarker Assays
2014
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
KRASMutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer
2007
Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
2000
Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis
2010
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
2005
High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
2000 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
A Comprehensive Survey of Ras Mutations in Cancer
2012 Standout
Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1).
1993
Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
2008
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
2004 Standout
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Combination Treatment with Erlotinib and Pertuzumab against Human Tumor Xenografts Is Superior to Monotherapy
2005
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of Gary P. Gamble being referenced
Prognostic Markers in Resected Non–Small-Cell Lung Cancer: An Patients with 5 Year Follow-Up
1999
Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: A strategy for cloning the putative tumor suppressor gene
1992
The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer
2002
Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease
2003
Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.
2003
Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer
1999
Effect of Number of Lymph Nodes Sampled on Outcome in Patients With Stage I Non–Small-Cell Lung Cancer
2003